Effect of St John's wort on severity, frequency, and duration of hot flashes in premenopausal, perimenopausal and postmenopausal women: A randomized, double-blind, placebo-controlled study

Menopause

Volumn 17, Issue 2, 2010, Pages 326-331

  Abdali, Khadijeh ^a   Khajehei, Marjan ^a   Tabatabaee, Hamid Reza ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Duration; Frequency; Hot flashes; Menopause; Severity; St John's wort

Indexed keywords

HYPERICUM PERFORATUM EXTRACT; HYPIRAN; PLACEBO; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADULT; ARTICLE; CLIMACTERIUM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EVENING DOSAGE; FEMALE; FOLLOW UP; HEADACHE; HOT FLUSH; HUMAN; HYPERICUM PERFORATUM; IRAN; LETHARGY; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MORNING DOSAGE; POSTMENOPAUSE; PREMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION;

ADMINISTRATION, ORAL; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HOT FLASHES; HUMANS; HYPERICUM; IRAN; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERIMENOPAUSE; PHYTOTHERAPY; PLANT EXTRACTS; POSTMENOPAUSE; PREMENOPAUSE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 77949351771     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e3181b8e02d     Document Type: Article

References (28)

1. Jones NL, Judd HL. Menopause & premenopause. In: DeCherney AH, Nathan L, eds. Current Obstetrics and Gynecologic Diagnosis & Treatment, 9th ed. New York, NY: McGraw Hill, 2003:1018-1041.
2. Freedman RR. Menopausal hot flashes. In: Lobo R, Kesey J, eds. Menopause Biology and Pathobiology. San Diego, CA: Academic Press, 2000:215-225.
3. Glazier M, Gina MB, Bowman MA. A review of the evidence for the use of phytoestrogens as a replacement for traditional estrogen replacement therapy. Arch Intern Med 2001;161:1161-1172.
4. Carpenter JS. The Hot Flash Related Daily Interference Scale: a tool for assessing the impact of hot flashes on quality of life following breast cancer. J Pain Symptom Manage 2001;22:979-989.
5. National Institutes of Health. Facts about postmenopausal hormone therapy. Washington, DC: US Department of Health and Human Services; 2002. Available at: http://www.nhlbi.nih.gov/ health /women/ pht-facts.htm. Accessed 2005.
6. Wetzel W. Alternative and complementary therapy. In: Lowdermilk DL, Perry SE, eds. Maternity and Women's Health. Philadelphia, PA: Mosby Elsevier, 2007:85.
7. Lecrubier Y, Clerc G, Didi R, Kieser M. Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial. Am J Psychiatry 2002;159:1361-1366.
8. Linde K, Mulrow CD. St. John's wort for depression. Cochrane Library 1999;1:1-17.
9. Blumel JE, Castelo-Branco C, Cancelo M, et al. Relationship between psychological complaints and vasomotor symptoms during climacteric. Maturitas 2004;49:205-210.
10. Gaster B, Holroyd J. St John's wort for depression. Arch Intern Med 2000;160:152-156.
11. Ramsay C, Walker M, Alexander J. Alternative medicine in Canada: use and public attitudes. Public Policy Sources 1999;21:3-31.
12. Adams MP, Josephson DL. Herbal and alternative therapies. Pharmacology for Nursing. Upper Saddle River, NJ: Pearson Prentice Hall; 2005:100-141.
13. Brambila DJ, McKinlay SM, Johannes CB. Defining the perimenopause for application in epidemiologic investigations. Am J Epidemiol 1994; 140:1091-1095.
14. Blatt M, Wiesbader H, Kupperman H. Vitamin E and climacteric syndrome. Arch Intern Med 1953;91:793-799.
15. European Scientific Cooperative on Phytotherapy. ESCOP Monographs: Cimicifugae RhizomaVBlack Cohosh. New York, NY: Thieme Verlag, 2003.
16. Rossouw JE, Anderson GL, Prentice RL. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. J Am Med Assoc 2002;288:321-333.
17. Keenan NL, Mark S, Fugh-Berman A, Browne D, Kaczmarczyk J, Hunter C. Severity of menopausal symptoms and use of both conventional and complementary/alternative therapies. Menopause 2003; 10:507-515.
18. Newton KM, Buist DS, Keenan NL, Anderson LA, LaCroix AZ. Use of alternative therapies for menopause symptoms: results of a population-based survey. Obstet Gynecol 2002;100:18-25.
19. Briese V, Stammwitz U, Friede M, Zepelin HH. Black cohosh with or without St. John's wort for symptom-specific climacteric treatmentV results of a large-scale, controlled, observational study. Maturitas 2007; 57:405-414.
20. Uebelhack R, Blohmer JU, Graubaum HJ, Busch R, Joerg Gruenwald J, Wernecke KD. Black cohosh and St. John's wort for climacteric complaints. Obstet Gynecol 2006;107:247-255.
21. Evans ML, Pritts E, Vittinghoff E, McClish K, Morgan KS, Jaffe RB. Management of postmenopausal hot flushes with venlafaxine hydro-chloride:a randomized, controlled trial. Obstet Gynecol 2005;105:161-166.
22. Wuttke W, Jarry H, Westphalen S, Christoffel V, Seidlova-Wuttke D. Phytoestrogens for hormone replacement therapy. J Steroid Biochem Mol Biol 2002;83:133-147.
23. Al-Akoum M, Maunsell E, Verreault R, Provencher L, Otis H, Dodin S. Effects of Hypericum perforatum (St. John's wort) on hot flashes and quality of life in perimenopausal women: a randomized pilot trial. Menopause 2009;16:307-314.
24. Krebs EE, Ensrud KE, MacDonald R, et al. Phytoestrogens for treatment of menopausal symptoms: a systematic review. Obstet Gynecol. 2004; 104:824-836.
25. Lethaby AE, Brown J, Marjoribanks J, Kronenberg F, Roberts H, Eden J. Phytoestrogens for vasomotor menopausal symptoms. Cochrane Database Syst Rev 2007;4:CD001395.
26. Rossouw R, Brzezinski A, Hochner-Celnikier D. Herbal remedies for menopausal symptoms: are we cautious enough? Eur J Contracept Reprod Health Care 2008;13:133-137.
27. Tempfer CB, Bentz EK, Leodolter S, et al. Phytoestrogens in clinical practice: a review of the literature. Fertil Steril 2007;87:1243-1249.
28. Barnes J, Anderson LA, Phillipson JD. St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties. J Pharm Pharmacol 2001;53:583-600.